Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 30   Next >
 
2.  
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 1998 Dec 1 (revised 2014 May 1). NGC:010355
Department of Health and Human Services (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
3.  
Management of lung cancer. A national clinical guideline. 1998 Feb (revised 2014 Feb). NGC:010220
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
5.  
Preexposure prophylaxis for the prevention of HIV Infection in the United States - 2014. 2011 Jan 28 (revised 2014). NGC:010403
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
6.  
7.  
8.  
Management of epithelial ovarian cancer. A national clinical guideline. 2003 Oct (revised 2013 Nov). NGC:010080
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Non-small cell lung cancer stage IV. 2011 Jun (revised 2013 Nov). NGC:010261
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10.  
Muscle invasive and locally advanced/metastatic bladder cancer. 2011 Jan (revised 2013 Oct). NGC:010249
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Nonmuscle invasive bladder cancer. 2011 Jan (revised 2013 Oct). NGC:010250
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12.  
Optimal use of taxanes in metastatic breast cancer (MBC). 2013 Sep. NGC:010373
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13.  
Uterine sarcoma. 2011 Aug (revised 2013 Sep). NGC:010272
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
Hepatitis B virus. 2003 Mar (revised 2013 Aug). NGC:010214
New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by the developer(s)
15.  
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer. 2013 May. NGC:009893
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Malignant pleural mesothelioma. 2010 Aug (revised 2012 Dec). NGC:010257
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
HIV prophylaxis following occupational exposure. 2003 Mar (revised 2012 Oct). NGC:009558
New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by the developer(s)
18.  
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer. 2012 Aug. NGC:009311
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Practice parameters for the management of colon cancer. 2004 Aug (revised 2012 Aug). NGC:009295
American Society of Colon and Rectal Surgeons - Medical Specialty Society. View all guidelines by the developer(s)
1-20 of 30   Next >